Search Within

Hematologic Malignancies Research

  1. "Meeting abstract"
Formats
  1. Meeting Abstract (1192)
Groups
  1. Center for Hematologic Malignancies (1192)
  2. Department of Medicine (1022)
  3. Hematologic Malignancies, Division of (957)
  4. GSK Faculty (918)
  5. Sloan Kettering Institute Faculty (755)
  6. Molecular Pharmacology and Chemistry Program Faculty (645)

More Groups

People
  1. Michel Sadelain (287)
  2. Alexander Lesokhin (214)
  3. David Scheinberg (192)
  4. Carl Landgren (155)
  5. Renier Brentjens (149)
  6. Sergio Giralt (148)

More People

Years
  1. 2023 (97)
  2. 2022 (65)
  3. 2021 (47)
  4. 2020 (59)
  5. 2019 (81)
  6. 2018 (78)

More Years

Publications
  1. Blood (536)
  2. Cancer Research (83)
  3. Journal of Clinical Oncology (75)
  4. Clinical Lymphoma, Myeloma and Leukemia (64)
  5. Molecular Therapy (47)
  6. Biology of Blood and Marrow Transplantation (45)

More Publications

Publishers
  1. American Society of Hematology (536)
  2. Elsevier Inc. (143)
  3. American Association for Cancer Research (126)
  4. American Society of Clinical Oncology (75)
  5. Nature Publishing Group (69)
  6. Ferrata Storti Foundation (25)

More Publishers

Results (1192)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A dysfunctional program imprinted by Prostaglandin E2 signaling shuts off NK cell communication pathways and disables immunosurveillance of metastasis
    Meeting Abstract

    Pedde, A.; Baumann, T.; Kim, H.; Donakonda, S.; Bayerl, F.; Meiser, P.; Hirschberger, A.; Klement, C.; Grassmann, S.; Òˆllinger, R.; more...
    European Journal of Immunology (2023)

    Fulltext@MSK | Save
  • Dose escalation of ISB 1342, a novel CD38xCD3 bispecific antibody, in patients with relapsed / refractory multiple myeloma (RRMM)
    Meeting Abstract

    Kapoor, P.; Stevens, D. A.; Leleu, X.; Merzoug, K. B.; Karlin, L.; Manier, S.; Chalopin, T.; Hulin, C.; Perrot, A.; Berdeja, J. G.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Long-term efficacy and safety of elranatamab monotherapy in the phase 2 magnetismm-3 trial in relapsed or refractory multiple myeloma (RRMM)
    Meeting Abstract

    Tomasson, M.; Iida, S.; Niesvizky, R.; Mohty, M.; Bahlis, N. J.; Martinez-Lopez, J.; Koehne, G.; Otero, P. R.; Prince, H. M.; Viqueira, A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Clinical factors associated with cytokine release syndrome and dosing recommendations for restarting elranatamab following an interruption
    Meeting Abstract

    Niesvizky, R.; Arnulf, B.; Mohty, M.; Nooka, A. K.; Manier, S.; Tomasson, M.; Bahlis, N. J.; Irby, D.; Hibma, J.; Viqueira, A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Manufacturing, characterization and anti-tumor activity of allogeneic CD19-CAR cytokine-induced killer (CIK) cells engineered with non-viral sleeping beauty transposon system and armored with IL-18
    Meeting Abstract

    Contreras-Ruiz, L.; Pace, B.; Kohnke, D. E.; Viruet, L.; Adams, M.; Krisko, J. F.; Leesnitzer, N.; Velie, M.; Tettamanti, S.; Pisani, I.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Efficacy and safety of elranatamab in Black patients with relapsed/refractory multiple myeloma (RRMM): A Subgroup analysis of the magnetismm studies
    Meeting Abstract

    Varshavsky-Yanovsky, A.; Jethava, Y.; Stevens, D. A.; Nooka, A. K.; Stiff, P. J.; Perez-Cruz, I.; Leip, E.; Lesokhin, A.
    Blood (2023)

    Fulltext@MSK | Save
  • Whole-genome sequencing reveals distinct mutational signatures in multiple myeloma patients with African ancestry compared with those of non-African ancestry
    Meeting Abstract

    Maclachlan, K. H.; Blaney, P.; Cirrincione, A.; Chu, T. R.; Poos, A. M.; Brown, E. E.; Manasanch, E. E.; Hoering, A.; Hou, L. M.; Gagler, D.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Potent and target specific cytotoxicity of PRAME TCR mimic CAR T cells in KMT2A-rearranged AML patient-derived xenograft model
    Meeting Abstract

    Kirkey, D. C.; Robinson, L.; Hylkema, T.; Loeb, A.; Ries, R. E.; McKay, C.; Root, C.; Pardo, L.; Loeb, K. R.; Le, Q.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Dietary patterns among individuals with plasma cell disorders compared to the general US population
    Meeting Abstract

    Traore, K.; Taneja, A.; Gorshein, E.; Castro, F.; Derkach, A.; Martinez, J. A. H.; Serrano, E.; Lesokhin, A.; Ahlstrom, J. M.; Block, T.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • GLUT1 overexpression enhances 19-28z CAR-T cell expansion and metabolic fitness
    Meeting Abstract

    Shi, Y.; Kotchetkov, I. S.; Hanina, S. A.; Sadelain, M.
    Blood (2023)

    Fulltext@MSK | Save